The terminal basal mitosis of chicken retinal Lim1 horizontal cells is not sensitive to cisplatin-induced cell cycle arrest

Cell Cycle

Volumn 13, Issue 23, 2014, Pages 3698-3706

  Fard, Shahrzad Shirazi ^a   Thyselius, Malin ^a   All Ericsson, Charlotta ^b   Hallböök, Finn ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

ATM ATR; Cell cycle regulation; Chk1; Cyclin B1 Cdk1; Nutlin3a; P21; P53; Retina

Indexed keywords

CASPASE 3; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CISPLATIN; CYCLIN B1; PROTEIN P21; PROTEIN P53; ANTINEOPLASTIC AGENT; LHX1 PROTEIN, HUMAN; LIM HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE CHECKPOINT; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; LEGHORN CHICKEN; MITOSIS; NONHUMAN; PROTEIN EXPRESSION; RETINA HORIZONTAL NERVE CELL; ANIMAL; BIOSYNTHESIS; CHICKEN; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE CHECKPOINTS; CHICKENS; CISPLATIN; LIM-HOMEODOMAIN PROTEINS; MITOSIS; RETINAL HORIZONTAL CELLS; TRANSCRIPTION FACTORS;

EID: 84920614630     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.964985     Document Type: Article

References (42)

1. Turner DL, Snyder EY, Cepko CL. Lineage-independent determination of cell type in the embryonic mouse retina. Neuron 1990; 4:833-45; PMID:2163263; http://dx.doi.org/10.1016/0896-6273(90)90136-4
2. Baye LM, Link BA. Interkinetic nuclear migration and the selection of neurogenic cell divisions during vertebrate retinogenesis. J Neurosci 2007; 27:10143-52; PMID:17881520; http://dx.doi.org/10.1523/ JNEUROSCI.2754-07.2007
3. Sauer F. Mitosis in the neural tube. J Comp Neurol 1935; 62:377-405; http://dx.doi.org/10.1002/cne. 900620207
4. Gotz M, Huttner WB. The cell biology of neurogenesis. Nat Rev Mol Cell Biol 2005; 6:777-88; PMID:16314867; http://dx.doi.org/10.1038/nrm1739
5. Shirazi Fard S, JarrinM, Boije H, Fillon V, All-Eriksson C, Hallbook F. Heterogenic final cell cycle by chicken retinal Lim1 horizontal progenitor cells leads to heteroploid cells with a remaining replicated genome. PLoS One 2013; 8: e59133; PMID:23527113; http://dx.doi.org/10.1371/ journal.pone.0059133
6. Godinho L, Williams PR, Claassen Y, Provost E, Leach SD, Kamermans M, Wong RO. Nonapical symmetric divisions underlie horizontal cell layer formation in the developing retina in vivo. Neuron 2007; 56:597-603; PMID:18031679
7. Murray A. Cell cycle checkpoints. Curr Opin Cell Biol 1994; 6:872-6; PMID:7880536; http://dx.doi.org/ 10.1016/0955-0674(94)90059-0
8. Fragel-Madeira L, Meletti T, Mariante RM, Monteiro RQ, Einicker-Lamas M, Bernardo RR, Lopes AH, Linden R. Platelet activating factor blocks interkinetic nuclear migration in retinal progenitors through an arrest of the cell cycle at the SG2 transition. PLoS One 2011; 6:e16058; PMID:21298035; http://dx.doi.org/ 10.1371/journal.pone.0016058
9. Shirazi Fard S, All-Ericsson C, Hallbook F. The heterogenic final cell cycle of chicken retinal Lim1 horizontal cells is not regulated by the DNA damage response pathway. Cell Cycle 2014; 13:408-17; PMID:24247150; http://dx.doi.org/10.4161/cc.27200
10. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858-68; PMID:9488723; http://dx.doi. org/10.1074/jbc.273.10.5858
11. Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001; 276:42462-7; PMID:11571274; http://dx.doi.org/ 10.1074/jbc.C100466200
12. Ward IM, Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem 2001; 276:47759-62; PMID:11673449; http://dx.doi.org/10.1074/jbc. M009785200
13. Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol 2008; 9:616-27; PMID:18594563; http://dx.doi.org/10.1038/nrm 2450
14. Bohlig L, Rother K. One function-multiple mechanisms: the manifold activities of p53 as a transcriptional repressor. J Biomed Biotechnol 2011; 2011:464916; PMID:21436991; http://dx.doi.org/10.1155/2011/464916
15. Zdzalik M, Pustelny K, Kedracka-Krok S, Huben K, Pecak A, Wladyka B, Jankowski S, Dubin A, Potempa J, Dubin G. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73. Cell Cycle 2010; 9:4584-91; PMID:21088494; http:// dx.doi.org/10.4161/cc.9.22.13871
16. Marine JC, Lozano G. Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ 2010; 17:93-102; PMID:19498444; http://dx.doi.org/10.1038/ cdd.2009.68
17. Taylor WR, Stark GR. Regulation of the G2M transition by p53. Oncogene 2001; 20:1803-15; PMID:11313928; http://dx.doi.org/10.1038/sj.onc. 1204252
18. Bartek J, Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 2001; 13:738-47; PMID:11698191; http://dx.doi. org/10.1016/S0955-0674(00)00280-5
19. Vuong L, Conley SM, Al-Ubaidi MR. Expression and role of p53 in the retina. Invest Ophthalmol Vis Sci 2012; 53:1362-71; PMID:22427613; http://dx.doi. org/10.1167/iovs.11-8909
20. Hamburger V, Hamilton HL. A series of normal stages in the development of the chick embryo. J Morphol 1951; 88:49-92; PMID:24539719
21. Jackson JR, Gilmartin A, Imburgia C, Winkler JD, Marshall LA, Roshak A. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Cancer Res 2000; 60:566-72; PMID:10676638
22. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003; 22:7265-79; PMID:14576837; http://dx.doi.org/ 10.1038/sj.onc.1206933
23. Damia G, Filiberti L, Vikhanskaya F, Carrassa L, Taya Y, D'Incalci M, D'incalci M, Broggini M. Cisplatinum and taxol induce different patterns of p53 phosphorylation. Neoplasia 2001; 3:10-6; PMID:11326311; http://dx.doi.org/10.1038/sj.neo.7900122
24. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366:701-4.
25. Pietrancosta N, Maina F, Dono R, Moumen A, Garino C, Laras Y, Burlet S, Quéléver G, Kraus JL. Novel cyclized Pifithrin-alpha p53 inactivators: synthesis and biological studies. Bioorg Med Chem Lett 2005; 15:1561-4; PMID:15745797; http://dx.doi.org/ 10.1016/j.bmcl.2005.01.075
26. Scoumanne A, Cho SJ, Zhang J, Chen X. The cyclindependent kinase inhibitor p21 is regulated by RNAbinding protein PCBP4 via mRNA stability. Nucleic Acids Res 2011; 39:213-24; PMID:20817677; http:// dx.doi.org/10.1093/nar/gkq778
27. Yang A, McKeon F. P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 2000; 1:199-207; PMID:11252895; http://dx.doi.org/10.1038/ 35043127
28. Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G. The p53p63p73 family of transcription factors: overlapping and distinct functions. J Cell Sci 2000; 113 (Pt 10):1661-70; PMID:10769197
29. Sheikh MS, Fornace AJ Jr. Role of p53 family members in apoptosis. J Cell Physiol 2000; 182:171-81; PMID:10623880; http://dx.doi.org/10.1002/(SICI) 1097-4652(200002)182:2%3c171::AID-JCP5%3e3.0. CO;2-3
30. Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 2006; 25:1125-42; PMID:16314846; http://dx.doi.org/ 10.1038/sj.onc.1209080
31. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, et al. In vivo activation of the p53 pathway by smallmolecule antagonists of MDM2. Science 2004; 303:844-8; PMID:14704432; http://dx.doi.org/ 10.1126/science.1092472
32. Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C, Teunisse A, Lam S, Ramos Y, Mohan A, et al. Inactivation of the p53 pathway in retinoblastoma. Nature 2006; 444:61-6; PMID:17080083; http://dx. doi.org/10.1038/nature05194
33. Sedletska Y, Giraud-Panis MJ, Malinge JM. Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways. Curr Med Chem Anticancer Agents 2005; 5:251-65; PMID:15992353; http://dx.doi.org/10.2174/1568011053765967
34. Gavet O, Pines J. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell 2010; 18:533-43; PMID:20412769; http://dx.doi.org/ 10.1016/j.devcel.2010.02.013
35. Castedo M, Perfettini JL, Roumier T, Kroemer G. Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ 2002; 9:1287-93; PMID:12478465; http://dx.doi.org/ 10.1038/sj.cdd.4401130
36. Chang LJ, Eastman A. Decreased translation of p21waf1 mRNA causes attenuated p53 signaling in some p53 wild-type tumors. Cell Cycle 2012; 11: 1818-26; PMID:22510560; http://dx.doi.org/10. 4161/cc.20208
37. Koster R, di Pietro A, Timmer-Bosscha H, Gibcus JH, van den Berg A, Suurmeijer AJ, Bischoff R, Gietema JA, de Jong S. Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. J Clin Invest 2010; 120:3594-605; PMID:20811155; http://dx.doi.org/10.1172/JCI41939
38. Dyer MA, Cepko CL. p27Kip1 and p57Kip2 regulate proliferation in distinct retinal progenitor cell populations. J Neurosci 2001; 21:4259-71; PMID:11404411
39. Moll UM, Petrenko O. The MDM2-p53 interaction. Mol Cancer Res 2003; 1:1001-8; PMID:14707283
40. Donovan SL, Corbo JC. Retinal horizontal cells lacking Rb1 sustain persistent DNA damage and survive as polyploid giant cells. Mol Biol Cell 2012; 23:4362-72; PMID:23015754; http://dx.doi.org/10.1091/mbc. E12-04-0293
41. Gavet O, Pines J. Activation of cyclin B1-Cdk1 synchronizes events in the nucleus and the cytoplasm at mitosis. J Cell Biol 2010; 189:247-59; PMID:20404109; http://dx. doi.org/10.1083/jcb.200909144
42. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999; 285:1733-7; PMID:10481009; http://dx.doi.org/10.1126/ science.285.5434.1733